Article info
PDFClinical ethics
Ethical allocation of future COVID-19 vaccines
- Correspondence to Rohit Gupta, Baylor College of Medicine, Houston, TX 77030-3411, USA; rohit.gupta{at}bcm.edu
Citation
Ethical allocation of future COVID-19 vaccines
Publication history
- Received August 26, 2020
- Revised December 7, 2020
- Accepted December 10, 2020
- First published December 17, 2020.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage
Other content recommended for you
- Will vaccination refusal prolong the war on SARS - CoV-2
- Two centuries of immunisation in the UK (part II)
- Postmarketing studies: can they provide a safety net for COVID-19 vaccines in the UK
- Multivalue ethical framework for fair global allocation of a COVID-19 vaccine
- Incentivising wealthy nations to participate in the COVID-19 Vaccine Global Access Facility (COVAX): a game theory perspective
- Rethinking global access to vaccines
- Covax must go beyond proportional allocation of covid vaccines to ensure fair and equitable access
- Science, medicine, and the future: Vaccines and vaccination
- Scarce vaccine supplies in an influenza pandemic should not be distributed randomly: reply to McLachlan
- Fairer financing of vaccines in a world living with COVID-19